Impact of the Covid 19 pandemic on pregnancy and its perinatal repercussions: a systematic review
DOI:
https://doi.org/10.56294/sctconf2024699Keywords:
Maternal Mortality, COVID 19, PregnancyAbstract
Since its inception, the COVID-19 infection has impacted the lives of at-risk populations, including pregnant women. Using clinical data and case studies, other authors have shown greater morbidity in pregnant women positive for the infection. This review includes articles from the PUBMED, SCOPUS, and SCIENCEDIRECT databases of international research. Data have shown that, compared to uninfected pregnant women, COVID is associated with increased risk and maternal and perinatal complications. Complications involving increased hospital admission were present mostly in the third trimester and included premature birth, spontaneous abortion, cesarean section, ICU admission, assisted mechanical ventilation, pneumonia, maternal death. Birth outcomes often included fetal distress, intrauterine death, and perinatal events found were low birth weight, severe sepsis, and neonatal death. The risk of vertical transmission is low. Few findings show pregnant women asymptomatic to the infection and this depends on whether the pregnant woman has other comorbidities such as obesity, high blood pressure, diabetes mellitus that increase the risk of maternal morbidity and mortality
References
1. World Health Organization. Pneumonia of unknown cause - China. Geneva: WHO, 2020 : https://www.who.int/csr/don/05-january-2020-pneumonia-of-unkown-cause-china/en
2. World Health Organization. WHO Director-General’s remarks at the media briefing on 2019-nCoV on 11 February 2020. Geneva: WHO, 2020 [citado junio 19, 2020]. Disponible en: https://www.who.int/dg/speeches/detail/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020.
3. World Health Organization. WHO Director-General’s opening remarks at the Mission briefing on Covid-19 - 28 May 2020. Geneva: WHO, 2020: https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-mission-briefing-oncovid-19---28-may-2020
4. Medina C, Chavira J, Aburto T, Nieto C, Contreras-Manzano A, Segura L, et al. Revisión rápida: evidencia de transmisión por Covid-19 e infecciones respiratorias agudas similares en espacios públicos abiertos. Vol. 63, Salud publica de Mexico. NLM (Medline); 2021. p. 232–41.
5. Organización Mundial de la Salud. Información básica sobre la COVID19. Ginebra: Organización Mundial de la Salud; 2021 https://www.who.int/es/emergencies/diseases/novel-coronavirus2019/question-and-answers-hub/q-a-detail/coronavirus-diseasecovid-19
6. Castro M. CovId-19 en el recién nacido. Archivos venezolanos de puericultura y pediatría. 2020;83(3):133–42.
7. Antonio A, Osorio S, Cabrera YH, Guardado YA, Nualla Pérez Y. Actualización sobre COVID-19 y embarazo Update on COVID-19 and pregnancy [Internet]. Available from: https://medisur.sld.cu/index.php/medisur/article/view/5360
8. Gaviria-Arbeláez SL, Uribe-Holguín A, Gil-Castaño LS, Uribe-Bravo SE, Serna-Galeano LE, Álvarez-Mesa C, et al. Prevalence of the risk of depression and worry in pregnant women in the context of the COVID-19 pandemic in Antioquia, Colombia, 2020-2021. Rev Colomb Obstet Ginecol. 2022;73(2):28–36.
9. Romero AFG, Agudelo GS, Gualdrón LMV. Evidencia actual de la infección por SARS-COV-2 en la gestación: Revisión de alcance. Vol. 13, Revista Cuidarte. Universidad de Santander; 2022.
10. Caracterización epidemiológica de la COVID-2019 en población obstétrica mexicana.
11. Dávila-Aliaga C, Hinojosa-Pérez R, Espinola-Sánchez M, Torres-Marcos E, Guevara-Ríos E, Espinoza-Vivas Y, et al. Maternal-perinatal outcomes in pregnant women with covid-19 in a level iii hospital in Peru. Rev Peru Med Exp Salud Publica. 2021;38(1):58–63.
12. Carranza-Asmat C, Espinola-Sánchez M, Guevara-Ríos E, Velásquez-Vásquez C, Ayala-Peralta F, Meza-Santibáñez L, et al. Pregnancy outcomes among women with and without COVID-19 in a national level III hospital in Peru. Rev Chil Obstet Ginecol. 2022 Jan 1;87(1):3–10.
13. Características obstétricas y perinatales en gestantes con SARS-CoV-2. Hospital Nacional Dos de Mayo. Available from: https://doi.org/10.35434/rcmhnaaa.2022.153.1369
14. Di Toro F, Gjoka M, Di Lorenzo G, De Santo D, De Seta F, Maso G, et al. Impact of COVID-19 on maternal and neonatal outcomes: a systematic review and meta-analysis. Vol. 27, Clinical Microbiology and Infection. Elsevier B.V.; 2021. p. 36–46.
15. Moher D, Liberati A, Tetzlaff J, Altman DG, Antes G, Atkins D, et al. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Vol. 6, PLoS Medicine. Public Library of Science; 2009.
16. Gámez-Gámez LN, Gámez-Borges LN, Sorrillo LJ, Matos-Quiala HA. Influencia de la COVID-19 en el embarazo desde la perspectiva de los cuidados intensivos. Rev Inf Cient 2021; 100(4). https://revinfcientifica.sld.cu/index.php/ric/article/view/3351
17. López P. Revisión de los riesgos maternos y perinatales en tiempos de COVID-19. Desafíos para el rol de la Matronería. REV CHIL OBSTET GINECOL. 2020;85:131–47.
18. Mayorga Albán SM, Valencia Escobar MN, Endara Salguero PE, Salas Hurtado IL. Embarazo e infección por coronavirus (COVID19). Journal of American Health 2021;4(1):10–18. https://doi.org/10.37958/jah.v4i1.58
19. Domínguez Pérez R, Alva Arroyo Nancy, Delgadillo Morales JJ, Enríquez López R, Flores Puente F, Portillo Urbina EF, et al. Enfermedad por coronavirus 2019 (COVID-19) y embarazo. Acta Médica Grupo Ángeles. 2020;18(4):399–406.
20. Morbilidad y mortalidad materna y neonatal entre mujeres embarazadas con y sin infección por COVID-19: estudio de cohorte multinacional INTERCOVID.
21. Fernanda M, Cruz I, Cerón Gutiérrez D, Morales AT, Carlos J, Ledezma R, et al. Complications from Covid-19 infection in pregnant women and neonates in the year 2020.
22. Guevara-Ríos E, Carranza-Asmat C, Zevallos-Espinoza K, Espinola-Sánchez M, Arango-Ochante P, Ayala-Peralta FD, et al. Prevalencia y caracterización de gestantes seropositivas para SARS-CoV-2. Revista Peruana de Investigación Materno Perinatal. 2020 Sep 4;9(2):11–5.
23. Parums D V. Editorial: Maternal SARS-CoV-2 infection and pregnancy outcomes from current global study data. Vol. 27, Medical Science Monitor. International Scientific Information, Inc.; 2021.
24. Novoa RH, Quintana W, Llancarí P, Urbina-Quispe K, Guevara-Ríos E, Ventura W. Maternal clinical characteristics and perinatal outcomes among pregnant women with coronavirus disease 2019. A systematic review. Vol. 39, Travel Medicine and Infectious Disease. Elsevier Inc.; 2021.
25. Wong SF, Chow KM, Leung TN, Ng WF, Ng TK, Shek CC, et al. Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome. Am J Obstet Gynecol. 2004 Jul;191(1):292–7.
26. Lokken EM, Huebner EM, Taylor GG, Hendrickson S, Vanderhoeven J, Kachikis A, et al. Disease severity, pregnancy outcomes, and maternal deaths among pregnant patients with severe acute respiratory syndrome coronavirus 2 infection in Washington State. Am J Obstet Gynecol. 2021 Jul 1;225(1):77.e1-77.e14.
27. Knight M, Bunch K, Vousden N, Morris E, Simpson N, Gale C, et al. Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: National population based cohort study. The BMJ. 2020 Jun 8;369.
28. Smith ER, Oakley E, Grandner GW, Rukundo G, Farooq F, Ferguson K, et al. Clinical risk factors of adverse outcomes among women with COVID-19 in the pregnancy and postpartum period: a sequential, prospective meta-analysis. Vol. 228, American Journal of Obstetrics and Gynecology. Elsevier Inc.; 2023. p. 161–77.
29. Urgellés S. Caracterización clínico epidemiológica de las gestantes sospechosas y positivas a la COVID-19. Revista Cubana de Medicina Militar [Internet]. 2020;49(3). Available from: http://scielo.sld.cuhttp://www.revmedmilitar.sld.cu
30. Sola A, Rodríguez S, Cardetti M, Dávila C. Perinatal COVID-19 in Latin America. Revista Panamericana de Salud Publica/Pan American Journal of Public Health. 2020;44(1).
31. Di Toro F, Gjoka M, Di Lorenzo G, De Santo D, De Seta F, Maso G, et al. Impact of COVID-19 on maternal and neonatal outcomes: a systematic review and meta-analysis. Vol. 27, Clinical Microbiology and Infection. Elsevier B.V.; 2021. p. 36–46.
32. de Melo GC, de Araújo KCGM. COVID-19 infection in pregnant women, preterm delivery, birth weight, and vertical transmission: A systematic review and meta-analysis. Cad Saude Publica. 2020 Jan 1;36(7).
33. Do Amaral WN, de Moraes CL, Rodrigues APDS, Noll M, Arruda JT, Mendonça CR. Maternal coronavirus infections and neonates born to mothers with sars-cov-2: A systematic review. Vol. 8, Healthcare (Switzerland). MDPI AG; 2020.
34. Marchand G, Patil AS, Masoud AT, Ware K, King A, Ruther S, et al. Systematic review and meta-analysis of COVID-19 maternal and neonatal clinical features and pregnancy outcomes up to June 3, 2021. Vol. 2, AJOG Global Reports. Elsevier Inc.; 2022.
35. Dubey P, Reddy SY, Manuel S, Dwivedi AK. Maternal and neonatal characteristics and outcomes among COVID-19 infected women: An updated systematic review and meta-analysis. Vol. 252, European Journal of Obstetrics and Gynecology and Reproductive Biology. Elsevier Ireland Ltd; 2020. p. 490–501
Published
Issue
Section
License
Copyright (c) 2024 Arturo Jhobet Vargas-Linares, Enzo Renatto Bazualdo-Fiorini, Edwin Pajares-Huaripata, Segundo Bueno-Ordoñez, Tito Urquiaga-Melquiades (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
